Shawn Tomasello Stock Option Grant

On June 17, 2026, Shawn Tomasello was granted 50,000 stock options for 4D Molecular Therapeutics, Inc. common stock. The options have an exercise price of $9.42 and an expiration date of June 16, 2036. The grant was made automatically under the company's non-employee director compensation program. The stock options vest over three years, with 1/3 vesting on June 17, 2027, and the remainder vesting in equal monthly installments until fully vested on June 17, 2029. Full vesting is also triggered upon a Change in Control, as defined by the 2020 Incentive Award Plan. Following this transaction, Tomasello holds 50,000 shares subject to these options.